Cargando…

Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA

BACKGROUND: Recurrent vulvovaginal candidosis (RVVC) is a chronic condition causing discomfort and pain. Health status and health-related quality of life (HRQoL) in RVVC were never previously described using validated questionnaires. The objective of this study is to describe subjective health statu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aballéa, Samuel, Guelfucci, Florent, Wagner, Julian, Khemiri, Amine, Dietz, Jean-Paul, Sobel, Jack, Toumi, Mondher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815627/ https://www.ncbi.nlm.nih.gov/pubmed/24119427 http://dx.doi.org/10.1186/1477-7525-11-169

Ejemplares similares

Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
por: Sustr, Valentina, et al.
Publicado: (2020)

“Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) – A systematic review and meta-analysis"
por: Siddiqui, Tasmiyah, et al.
Publicado: (2023)

Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France
por: Guelfucci, Florent, et al.
Publicado: (2013)

Clotrimazole for Vulvovaginal Candidosis: More Than 45 Years of Clinical Experience
por: Mendling, Werner, et al.
Publicado: (2020)

Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome
por: Oerlemans, Eline F. M., et al.
Publicado: (2020)

Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)
por: Farr, Alex, et al.
Publicado: (2021)

Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: A Review
por: Disha, Tasfia, et al.
Publicado: (2022)

Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion
por: Donders, Gilbert, et al.
Publicado: (2022)

The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation
por: Ignjatović, Aleksandra, et al.
Publicado: (2020)

Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
por: Novikova, N, et al.
Publicado: (2002)

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Measuring the health-related quality of life in young children: how far have we come?
por: Germain, Nicola, et al.
Publicado: (2019)

Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC
por: Jaeger, M., et al.
Publicado: (2016)

Vulvovaginal Trichosporonosis
por: Makela, Paul, et al.
Publicado: (2003)

Validation of the SavvyCheck™ Vaginal Yeast Test for Screening Pregnant Women for Vulvovaginal Candidosis: A Prospective, Cross-Sectional Study
por: Foessleitner, Philipp, et al.
Publicado: (2021)

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al
por: Toumi, Mondher, et al.
Publicado: (2020)

Pathogenesis and treatment of oral candidosis
por: Williams, David, et al.
Publicado: (2011)

A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environments
por: Massetti, Marc, et al.
Publicado: (2015)

Factors influencing the COVID-19 daily deaths' peak across European countries
por: Jabłońska, Katarzyna, et al.
Publicado: (2021)

Oropharyngeal Candidosis in HIV-Infected Patients—An Update
por: Patil, Shankargouda, et al.
Publicado: (2018)

The quality of life of Spanish patients with Huntington's disease measured with H-QoL-I and EQ-5D
por: Dorey, Julie, et al.
Publicado: (2016)

Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis
por: Sobel, Jack D
Publicado: (2013)

Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts and Initiatives
por: Chachoua, Lylia, et al.
Publicado: (2020)

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
por: Pochopień, Michał, et al.
Publicado: (2021)

Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment
por: Toumi, Mondher, et al.
Publicado: (2017)

Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative Study
por: Hawken, Natalia, et al.
Publicado: (2016)

Current process and future path for health economic assessment of pharmaceuticals in France
por: Toumi, Mondher, et al.
Publicado: (2015)

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
por: Nazir, Jameel, et al.
Publicado: (2018)

Pharmaceutical expenditure forecast model to support health policy decision making
por: Rémuzat, Cécile, et al.
Publicado: (2014)

Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Candida Species Isolated from Women with RVVC
por: Nikoomanesh, Fatemeh, et al.
Publicado: (2023)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
por: Zhou, Junwen, et al.
Publicado: (2019)

Oropharyngeal candidosis relative frequency in radiotherapy patient for head and neck cancer
por: Suryawanshi, Hema, et al.
Publicado: (2012)

Immunohistochemical Expression Patterns of Inflammatory Cells Involved in Chronic Hyperplastic Candidosis
por: Williams, Ailish, et al.
Publicado: (2019)

Oral Candidosis: Pathophysiology and Best Practice for Diagnosis, Classification, and Successful Management
por: Lu, Shin-Yu
Publicado: (2021)

The Catestatin-Derived Peptides Are New Actors to Fight the Development of Oral Candidosis
por: Mancino, Davide, et al.
Publicado: (2022)

Quality of life is predictive of relapse in schizophrenia
por: Boyer, Laurent, et al.
Publicado: (2013)

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach
por: Han, Ru, et al.
Publicado: (2021)

Gene therapy randomised clinical trials in Europe – a review paper of methodology and design
por: Ilieva, Krassimira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ln0qqnubp8gpo9fhnd9jop2ugu